• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性雀斑进展为恶性雀斑样黑色素瘤的风险。

The risk of progression of lentigo maligna to lentigo maligna melanoma.

作者信息

Weinstock M A, Sober A J

出版信息

Br J Dermatol. 1987 Mar;116(3):303-10. doi: 10.1111/j.1365-2133.1987.tb05843.x.

DOI:10.1111/j.1365-2133.1987.tb05843.x
PMID:3567069
Abstract

An analysis is presented which estimates the risk of progression of lentigo maligna (LM) to lentigo maligna melanoma (LMM) in U.S. whites using three data sources: the Health and Nutrition Examination Survey I for estimation of the age-specific prevalence of LM; the Surveillance, Epidemiology, and End Results Program for estimation of the age-specific incidence of melanoma; and the data from three melanoma registries for estimation of the age-specific case fraction of LMM among all invasive melanomas. The risk varies with age and is likely to be greater than estimated here for patients who present themselves for evaluation of changes in a lesion of LM. Our analysis suggests that the risk of progression from LM to LMM is substantially lower than is commonly believed.

摘要

本研究进行了一项分析,利用三个数据源估计美国白人中恶性雀斑(LM)进展为恶性雀斑样痣黑色素瘤(LMM)的风险:一是健康与营养检查调查I,用于估计LM的年龄特异性患病率;二是监测、流行病学和最终结果计划,用于估计黑色素瘤的年龄特异性发病率;三是来自三个黑色素瘤登记处的数据,用于估计所有侵袭性黑色素瘤中LMM的年龄特异性病例比例。风险随年龄而异,对于那些因LM病变变化前来评估的患者,实际风险可能高于此处估计值。我们的分析表明,从LM进展为LMM的风险远低于普遍认知。

相似文献

1
The risk of progression of lentigo maligna to lentigo maligna melanoma.恶性雀斑进展为恶性雀斑样黑色素瘤的风险。
Br J Dermatol. 1987 Mar;116(3):303-10. doi: 10.1111/j.1365-2133.1987.tb05843.x.
2
Incidence trends of lentigo maligna and lentigo maligna melanoma in the United States from 2000 to 2019.美国 2000 年至 2019 年恶性雀斑样痣和恶性雀斑样黑素瘤的发病趋势。
Int J Dermatol. 2024 May;63(5):647-654. doi: 10.1111/ijd.16982. Epub 2024 Jan 4.
3
The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.澳大利亚不断增长的恶性雀斑样痣和恶性雀斑样黑素瘤问题:基于人群的诊断和管理数据。
Australas J Dermatol. 2019 May;60(2):118-125. doi: 10.1111/ajd.12928. Epub 2018 Oct 9.
4
Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia.加泰罗尼亚地区恶性雀斑样痣和恶性雀斑样黑素瘤发病率的增加。
Int J Dermatol. 2019 May;58(5):577-581. doi: 10.1111/ijd.14334. Epub 2018 Dec 13.
5
[Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].[恶性雀斑样痣及恶性雀斑样痣黑色素瘤:24例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2018 Oct 8;47(10):769-774. doi: 10.3760/cma.j.issn.0529-5807.2018.10.007.
6
Epidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989-2013.1989 - 2013年荷兰恶性雀斑样痣及恶性雀斑样痣黑素瘤的流行病学
J Invest Dermatol. 2016 Oct;136(10):1955-1960. doi: 10.1016/j.jid.2016.06.014. Epub 2016 Jun 24.
7
Lentigo maligna and malignant melanoma.恶性雀斑样痣和恶性黑色素瘤。
Can Med Assoc J. 1966 Oct 22;95(17):846-51.
8
Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000.恶性雀斑样痣黑色素瘤亚型发病率上升:1990 - 2000年加利福尼亚州北部及全国趋势
J Invest Dermatol. 2005 Oct;125(4):685-91. doi: 10.1111/j.0022-202X.2005.23852.x.
9
Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.免疫冷冻疗法作为单一疗法治疗恶性雀斑样痣或与手术切除联合治疗恶性雀斑样痣黑素瘤。
J Dermatol. 2018 May;45(5):564-570. doi: 10.1111/1346-8138.14248. Epub 2018 Feb 11.
10
Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.眼部恶性雀斑及恶性雀斑样黑色素瘤的映射连续切除术
Ophthalmology. 2003 Oct;110(10):2011-8. doi: 10.1016/S0161-6420(03)00670-5.

引用本文的文献

1
A Review of Melanoma Subtypes: Genetic and Treatment Considerations.黑色素瘤亚型综述:遗传学与治疗考量
J Surg Oncol. 2025 Mar;131(3):356-364. doi: 10.1002/jso.27953. Epub 2024 Oct 16.
2
Incomplete Excision Rate for Lentigo Maligna and Associated Risk Factors.恶性雀斑样痣的不完全切除率及相关危险因素。
Acta Derm Venereol. 2024 Oct 3;104:adv40535. doi: 10.2340/actadv.v104.40535.
3
Radiation and Melanoma: Where Are We Now?辐射与黑色素瘤:我们现在处于什么阶段?
Curr Oncol Rep. 2024 Aug;26(8):904-914. doi: 10.1007/s11912-024-01557-y. Epub 2024 Jun 1.
4
Overdiagnosis of Melanoma: Is It a Real Problem?黑色素瘤的过度诊断:这是一个实际问题吗?
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023246. doi: 10.5826/dpc.1304a246.
5
Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review.原位黑色素瘤的局部和病灶内免疫治疗:综述
Cancers (Basel). 2023 Sep 8;15(18):4468. doi: 10.3390/cancers15184468.
6
Delphi Consensus Among International Experts on the Diagnosis, Management, and Surveillance for Lentigo Maligna.国际专家关于恶性雀斑样痣诊断、管理及监测的德尔菲共识
Dermatol Pract Concept. 2023 Jul 1;13(3):e2023244. doi: 10.5826/dpc.1303a244.
7
Lentigo Maligna of the head and neck: A retrospective study assessing surgical excision margins in a South African population.头颈部恶性雀斑样痣:一项评估南非人群手术切缘的回顾性研究。
JAAD Int. 2022 Apr 28;7:169-176. doi: 10.1016/j.jdin.2022.01.008. eCollection 2022 Jun.
8
Linguine technique for excision of lentigo maligna and poorly defined non-melanotic skin cancer - A case series.用于切除恶性雀斑样痣和边界不清的非黑素性皮肤癌的细面条技术——病例系列
JPRAS Open. 2019 Jan 12;19:111-117. doi: 10.1016/j.jpra.2019.01.005. eCollection 2019 Mar.
9
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma.慢性日光损伤性黑色素瘤的肿瘤遗传异质性分析。
Pigment Cell Melanoma Res. 2020 May;33(3):480-489. doi: 10.1111/pcmr.12851. Epub 2019 Dec 23.
10
Experience with Treating Lentigo Maligna with Definitive Radiotherapy.采用根治性放射治疗治疗恶性雀斑样痣的经验
Dermatol Res Pract. 2018 Jul 15;2018:7439807. doi: 10.1155/2018/7439807. eCollection 2018.